Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BWAY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Market Cap
Shares Outstanding
Share in Float
Dividende
Earning Date
No Data
Price Target
Average Volume
Beta
Range
Industry
Website
Sector
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
zacks.com
10 hours ago
zacks.com
13 hours ago
seekingalpha.com
15 hours ago
Earnings Growth
YoY
Current
Estimates
Sales Growth
YoY
Current
Estimates
Return on Equity
QoQ
Institutionnal Ownership
QoQ
Q3.23
N/A
-0.01
vs -0.30
Q4.23
+104%
0.01
vs -0.24
Q1.24
+107%
0.01
vs -0.14
Q2.24
+140%
0.04
vs -0.10
Q3.24
+500%
0.04
vs -0.01
Q4.24
+700%
0.08
vs 0.01
Q1.25
+300%
0.04
vs 0.01
Q2.25
+150%
0.1
vs 0.04
Q3.25
N/A
0.04
vs 0.04
Q4.25
-44%
0.04
vs 0.08
Q3.23
+61%
8.3M vs 5.2M
Q4.23
+50%
9M vs 6M
Q1.24
+37%
9.1M vs 6.6M
Q2.24
+28%
10M vs 7.8M
Q3.24
+27%
10.5M vs 8.3M
Q4.24
+26%
11.4M vs 9M
Q1.25
+27%
11.5M vs 9.1M
Q2.25
+26%
12.6M vs 10M
Q3.25
+23%
12.9M vs 10.5M
Q4.25
+19%
13.6M vs 11.4M
Q1.23
-6%
-0.06
vs -0.09
Q2.23
-4%
-0.04
vs -0.06
Q3.23
-1%
-0.01
vs -0.04
Q4.23
+0%
0
vs -0.01
Q1.24
+0%
0
vs 0
Q2.24
+1%
0.01
vs 0
Q3.24
+2%
0.02
vs 0.01
Q4.24
+2%
0.02
vs 0.02
Q1.25
+2%
0.02
vs 0.02
Q2.25
+3%
0.03
vs 0.02
Q1.23
13
13
vs 15
-13%
Q2.23
16
16
vs 13
23%
Q3.23
15
15
vs 16
-6%
Q4.23
26
26
vs 15
73%
Q1.24
29
29
vs 26
12%
Q2.24
27
27
vs 29
-7%
Q3.24
32
32
vs 27
19%
Q4.24
40
40
vs 32
25%
Q1.25
44
44
vs 40
10%
Q2.25
43
43
vs 44
-2%
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
NASDAQ
-0.38Â ( -2.56%)
Pre-market 14.68$
0.20 (1.42%)
Relative Strenght
91
Volume Buzz
58%
Earning Acce
No
Dist 52w H.
4%Relative Strength
BWAY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
389%2026-Revenue
125%2026-EPS
-356%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
No Data Available